Detail of the clinical trial

Title of the trial A double-blind, placebo-controlled, dose-ranging study of the efficacy and safety of SSR149744C, 100 or 300 mg for the prevention of ventricular arrhytmia-triggered implantable cardioverter-defibrillator interventions
EudraCT number 2004-004799-35
Protocol number DRI5349
Sponsor Sanofi-Aventis Recherche et Développement, Montpellier, France
Indications Cardio-vascular diseases
Diagnosis ventricular arrhytmia-triggered implantable cardioverter-defibrillator interventions
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2005
Date of approval by Institute (SÚKL) 18.05.2005
Date of approval by EC 25.05.2005
Date of initiation CT in ČR 07.10.2005
Date of ending CT in ČR 01.02.2007
Notice
Sites I. interní klinika, Fakultní nemocnice U Sv. Anny v Brně, Pekařská 53, 656 91 BRNO
I. interní klinika, Fakultní nemocnice Olomouc, I. P. Pavlova 6, 775 02 OLOMOUC
Kardiologická klinika, Fakultní nemocnice Brno-Bohunice, Jihlavská 20, 602 00 BRNO-BOHUNICE
Kardiologická klinika, Institut klinické a experimentální medicíny, Vídeňská 800, 140 00 PRAHA 4

‹‹ Back to list